Sfoglia per AUTORE
PIRRO E
Collezione AOU San Luigi di Orbassano

  

Items : 17

The effect of vitamin D pathway genes and deferasirox pharmacogenetics on liver iron in thalassaemia major patients. in The pharmacogenomics journal / Pharmacogenomics J. 2019 Oct;19(5):417-427. doi: 10.1038/s41397-019-0071-7. Epub 2019 Jan 17.
2019
ASL Città di Torino
AOU San Luigi di Orbassano

Piga A; De Nicolò A; Avataneo V; Massano D; Pirro E; Longo F; De Francia S; Cusato J; Allegra S; D'Avolio A;

Role of CYP1A1, ABCG2, CYP24A1 and VDR gene polymorphisms on the evaluation of cardiac iron overload in thalassaemia patients. in Pharmacogenetics and genomics / Pharmacogenet Genomics. 2018 Sep;28(9):199-206. doi: 10.1097/FPC.0000000000000348.
2018
ASL Città di Torino
AOU San Luigi di Orbassano

Piga A; De Nicolò A; Avataneo V; Pirro E; Massano D; De Francia S; Longo F; Cusato J; Allegra S; D'Avolio A;

Role of CYP24A1, VDR and GC gene polymorphisms on deferasirox pharmacokinetics and clinical outcomes. in The pharmacogenomics journal / Pharmacogenomics J. 2018 May 22;18(3):506-515. doi: 10.1038/tpj.2017.43. Epub 2017 Nov 21.
2018
ASL Città di Torino
AOU San Luigi di Orbassano

Piga A; De Nicolò A; Massano D; Pirro E; Longo F; Arduino A; De Francia S; Cusato J; Allegra S; D'Avolio A; Allegra S; Cusato J; De Francia S; Arduino A; Longo F; Pirro E; Massano D; De Nicolò A; Piga A; D'Avolio A;

Pharmacogenetic of voriconazole antifungal agent in pediatric patients. in Pharmacogenomics / Pharmacogenomics. 2018 Jul 1;19(11):913-925. doi: 10.2217/pgs-2017-0173. Epub 2018 Jun 19.
2018
ASL Città di Torino
AOU San Luigi di Orbassano

D'Avolio A; Perri GD; Avataneo V; Nicolò A; Cusato J; Carcieri C; Francia S; Pirro E; Fatiguso G; Allegra S;

Therapeutic drug monitoring of voriconazole for treatment and prophylaxis of invasive fungal infection in children. in British journal of clinical pharmacology / Br J Clin Pharmacol. 2018 Jan;84(1):197-203. doi: 10.1111/bcp.13401. Epub 2017 Sep 24.
2018
ASL Città di Torino
AOU San Luigi di Orbassano

D'Avolio A; Di Perri G; De Nicolò A; Cusato J; Pirro E; Carcieri C; De Francia S; Favata F; Fatiguso G; Allegra S; Allegra S; Fatiguso G; De Francia S; Favata F; Pirro E; Carcieri C; De Nicolò A; Cusato J; Di Perri G; D'Avolio A;

Clinical relevance of deferasirox trough levels in ?-thalassemia patients. in Clinical and experimental pharmacology & physiology / Clin Exp Pharmacol Physiol. 2018 Feb;45(2):213-216. doi: 10.1111/1440-1681.12879. Epub 2017 Dec 4.
2018
ASL Città di Torino
AOU San Luigi di Orbassano

D'Avolio A; Cusato J; Pirro E; Piccione F; Longo F; De Francia S; Massano D; Allegra S; Piga A; Allegra S; Massano D; De Francia S; Longo F; Piccione F; Pirro E; Cusato J; D'Avolio A; Piga A;

Evaluation of Posaconazole Pharmacokinetics in Adult Patients with Invasive Fungal Infection. in Biomedicines / Biomedicines. 2017 Nov 20;5(4):66. doi: 10.3390/biomedicines5040066.
2017
ASL Città di Torino
AOU San Luigi di Orbassano

D'Avolio A; Di Perri G; Cusato J; Pirro E; Carcieri C; De Nicolò A; Favata F; De Francia S; Fatiguso G; Allegra S;

Pharmacokinetic evaluation of oral itraconazole for antifungal prophylaxis in children. in Clinical and experimental pharmacology & physiology / Clin Exp Pharmacol Physiol. 2017 Nov;44(11):1083-1088. doi: 10.1111/1440-1681.12822. Epub 2017 Sep 5
2017
ASL Città di Torino
AOU San Luigi di Orbassano

D'Avolio A; Di Perri G; De Nicolò A; Cusato J; Carcieri C; De Francia S; Favata F; Pirro E; Fatiguso G; Allegra S;

Circannual variation of mitotane and its metabolites plasma levels in patients with adrenocortical carcinoma. in The Journal of pharmacy and pharmacology / J Pharm Pharmacol. 2017 Nov;69(11):1524-1530. doi: 10.1111/jphp.12798. Epub 2017 Aug 15.
2017
ASL Città di Torino
AOU San Luigi di Orbassano

Tampellini M; Di Carlo F; Berruti A; Terzolo M; Daffara FC; Ferrero A; De Martino F; Piccione FM; Pirro E; Carrella S; Allegra S; De Francia S; Cusato J; D'Avolio A;

Deferasirox pharmacokinetic evaluation in ?-thalassaemia paediatric patients. in The Journal of pharmacy and pharmacology / J Pharm Pharmacol. 2017 May;69(5):525-528. doi: 10.1111/jphp.12559. Epub 2016 May 27.
2017
ASL Città di Torino
AOU San Luigi di Orbassano

D'Avolio A; Piga A; Massano D; Pirro E; De Francia S; Cusato J; Allegra S;

Deferasirox pharmacokinetic and toxicity correlation in ?-thalassaemia major treatment. in The Journal of pharmacy and pharmacology / J Pharm Pharmacol. 2016 Nov;68(11):1417-1421. doi: 10.1111/jphp.12638. Epub 2016 Sep 27.
2016
ASL Città di Torino
AOU San Luigi di Orbassano

Piga A; Massano D; Pirro E; Cusato J; De Francia S; Allegra S; D'Avolio A;

Deferasirox pharmacokinetics evaluation in a woman with hereditary haemochromatosis and heterozygous ?-thalassaemia. in Biomedicine & pharmacotherapy = Biomedecine & pharmacotherapie / Biomed Pharmacother. 2016 Dec;84:1510-1512. doi: 10.1016/j.biopha.2016.11.041. Epub 2016 Nov 20.
2016
ASL Città di Torino
AOU San Luigi di Orbassano

Piga A; Pirro E; Arduino A; Cusato J; Massano D; Longo F; De Francia S; Allegra S; D'Avolio A;

Plasma and intracellular imatinib concentrations in patients with chronic myeloid leukemia. in Therapeutic drug monitoring / Ther Drug Monit. 2014 Jun;36(3):410-2. doi: 10.1097/FTD.0000000000000013.
2014
AOU San Luigi di Orbassano

De Francia S; D?Avolio A; Ariaudo A; Pirro E; Piccione F; Simiele M; Fava C; Calcagno A; Di Perri G; Saglio G;

A new HPLC UV validated method for therapeutic monitoring of deferasirox in thalassaemic patients. in Journal of chromatography. B, Analytical technologies in the biomedical and life sciences / J Chromatogr B Analyt Technol Biomed Life Sci. 2012 Apr 15;893-894:127-33. doi: 10.1016/j.jchromb.20
2012
AOU San Luigi di Orbassano

De Francia S; Massano D; Piccione FM; Pirro E; Racca S; Di Carlo F; Piga A;

A new HPLC-UV validated method for therapeutic drug monitoring of tyrosine kinase inhibitors in leukemic patients. in Journal of chromatographic science / J Chromatogr Sci. 2011 Nov-Dec;49(10):753-7. doi: 10.1093/chrsci/49.10.753.
2011
AOU San Luigi di Orbassano

Pirro E; De Francia S; De Martino F; Fava C; Ulisciani S; Cambrin GR; Racca S; Saglio G; Di Carlo F;

New HPLC-MS method for the simultaneous quantification of the antileukemia drugs imatinib, dasatinib, and nilotinib in human plasma. in Journal of chromatography. B, Analytical technologies in the biomedical and life sciences / J Chromatogr B Analyt Technol Biomed Life Sci. 2009 Jun 15;877(18-19):1721-6. doi: 10.1016/j.jchromb
2009
AOU San Luigi di Orbassano

De Francia S; D'Avolio A; De Martino F; Pirro E; Baietto L; Siccardi M; Simiele M; Racca S; Saglio G; Di Carlo F; Di Perri G;

A new simple HPLC method for measuring mitotane and its two principal metabolites Tests in animals and mitotane-treated patients. in Journal of chromatography. B, Analytical technologies in the biomedical and life sciences / J Chromatogr B Analyt Technol Biomed Life Sci. 2006 Jun 6;837(1-2):69-75. doi: 10.1016/j.jchromb.200
2006
AOU San Luigi di Orbassano

De Francia S; Pirro E; Zappia F; De Martino F; Sprio AE; Daffara F; Terzolo M; Berruti A; Di Carlo F; Ghezzo F;

©2024 Tutti i diritti riservati. Biblioteca Virtuale per la Salute - Piemonte